Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience von Durmowicz, Anthony G, Witzmann, Kimberly A, Rosebraugh, Curtis J, Chowdhury, Badrul A

Volltext

Understanding the Relationship Between Sweat Chloride and Lung Function in Cystic Fibrosis: Response von Durmowicz, Anthony G., MD, Witzmann, Kimberly A., MD, Rosebraugh, Curtis J., MD, Chowdhury, Badrul A., MD, PhD

Volltext

Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis von Chen, Janet S., Witzmann, Kimberly A., Spilker, Theodore, Fink, Robert J., LiPuma, John J.

Volltext

Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products von Thomas, Brandon J., Absar, Mohammad, Delvadia, Renishkumar, Conti, Denise S., Witzmann, Kimberly, Guo, Changning

Volltext

Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays von Amini, Elham, Berger, Simon M., Schilling, Uta, Jiao, Yuanyuan, Chen, Mong-Jen, Bachhav, Sagar, Baumstein, Sandra M., Tang, Yufei, Al-Humiari, Mohammed, Leon Astudillo, Carmen E., Drescher, Stefanie, Iley, Teresa, Shur, Jagdeep, Price, Robert, Carrasco, Cynthia, Conti, Denise S., Delvadia, Renishkumar, Oguntimein, Oluwamurewa, Witzmann, Kimberly, Absar, Mohammad, Luke, Markham C., Boc, Susan, Dhapare, Sneha, Saluja, Bhawana, Bielski, Elizabeth, Newman, Bryan, Bulitta, Jürgen B., Hochhaus, Günther

Volltext